{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:05Z","timestamp":1790655065388,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejphar.2016.11.049","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T19:10:37Z","timestamp":1480533037000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure"],"prefix":"10.1016","volume":"795","author":[{"given":"Shinji","family":"Furuzono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh-ichi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejphar.2016.11.049_bib1","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1073\/pnas.95.16.9424","article-title":"Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism","volume":"95","author":"Berger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejphar.2016.11.049_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004240050906","article-title":"Rescue of the mineralocorticoid receptor knock-out mouse","volume":"438","author":"Bleich","year":"1999","journal-title":"Pflug. Arch."},{"issue":"11","key":"10.1016\/j.ejphar.2016.11.049_bib3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/qjmed\/hcs106","article-title":"Hyperkalaemia in the age of aldosterone antagonism","volume":"105","author":"Chapagain","year":"2012","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.049_bib4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.111.186072","article-title":"Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease","volume":"59","author":"Chen","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejphar.2016.11.049_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: from receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.ejphar.2016.11.049_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1479-5876-9-180","article-title":"The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism","volume":"9","author":"Eudy","year":"2011","journal-title":"J. Transl. Med."},{"issue":"23","key":"10.1016\/j.ejphar.2016.11.049_bib7","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","article-title":"Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage","volume":"111","author":"Fiebeler","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejphar.2016.11.049_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-2362.2012.02676.x","article-title":"Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances","volume":"42","author":"Galuppo","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2016.11.049_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI104605","article-title":"The effect of aortic constriction on aldosterone secretion in hypophysectomized dogs","volume":"41","author":"Ganong","year":"1962","journal-title":"J. Clin. Investig."},{"issue":"13","key":"10.1016\/j.ejphar.2016.11.049_bib10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ejphar.2016.11.049_bib11","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.CIR.0000163562.82134.8E","article-title":"Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction","volume":"111","author":"Katada","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejphar.2016.11.049_bib12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","article-title":"Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans","volume":"89","author":"Kawamoto","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.11.049_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.049_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/01.HYP.0000249902.09036.e7","article-title":"Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption","volume":"48","author":"Makhanova","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2016.11.049_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12967-014-0340-9","article-title":"Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects","volume":"12","author":"M\u00e9nard","year":"2014","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.049_bib16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2016.11.049_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.RES.40.3.275","article-title":"The renin-angiotensin-aldosterone system in rabbits with congestive heart failure produced by aortic constriction","volume":"40","author":"Morris","year":"1977","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.ejphar.2016.11.049_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ejphar.2016.11.049_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2016.11.049_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.108.184044","article-title":"Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart","volume":"104","author":"Qu","year":"2009","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.ejphar.2016.11.049_bib21","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ejphar.2016.11.049_bib22","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2016.11.049_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2003.10.012","article-title":"Vascular synthesis of aldosterone: role in hypertension","volume":"217","author":"Takeda","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"issue":"2","key":"10.1016\/j.ejphar.2016.11.049_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2016.11.049_bib25","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejphar.2016.11.049_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.steroids.2011.12.023","article-title":"Nongenomic actions of aldosterone and progesterone revisited","volume":"77","author":"Wendler","year":"2012","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.ejphar.2016.11.049_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:52:35Z","timestamp":1530870755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916307634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"alternative-id":["S0014299916307634"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}